{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:03:43Z","timestamp":1793113423161,"version":"4.5.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Patients undergoing axillary lymph node dissection (ALND) for breast cancer face a high risk of lymphedema, further increased by high body mass index (BMI) and insulin resistance. GLP-1 receptor agonists (GLP-1RAs) have the potential to reduce these risk factors, but their role in lymphedema has never been investigated. The purpose of this study was to determine if GLP-RAs can reduce the risk of lymphedema in patients undergoing ALND.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All patients who underwent ALND at a tertiary cancer center between 2010 and 2023 were reviewed. Patients with less than 2\u00a0years of follow-up from the time of ALND were excluded. Race, BMI, radiation, chemotherapy history, pre-existing diagnosis of diabetes, lymphedema development after ALND, and the use of GLP-1RAs were analyzed. Multivariate logistic regression analysis was performed to assess if there was a significant reduction in the risk of developing lymphedema after ALND. A sub-group analysis of non-diabetic patients was also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>3,830 patients who underwent ALND were included, 76 of which were treated with. GLP-1 RAs. The incidence of lymphedema in the GLP-1 RA cohort was 6.6% (5 patients). Compared to 28.5% (1,071 patients) in the non-GLP-1 RA cohort. On multivariate regression analysis, patients who were treated with GLP-1 RA were 86% less likely to develop lymphedema compared to the non-GLP-1 RA cohort (OR 0.14, 95% CI 0.04\u20130.32, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). A BMI of 25\u00a0kg\/m 2 or greater was a statistically significant risk factor for developing lymphedema with an odds ratio of 1.34 (95% CI 1.16\u20131.56, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). Diabetes was associated with lymphedema development that closely approached statistical significance (OR 1.32, 95% CI 0.97\u20131.78, <jats:italic>p<\/jats:italic> = 0.06). A subgroup analysis solely on non-diabetic patients showed similar results. The odds of developing lymphedema were 84% lower for patients without diabetes treated with GLP1-RAs compared to those who did not receive GLP-1 RAs (OR 0.16, 95% CI 0.05\u20130.40, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>GLP1-RAs appear to significantly reduce the risk of lymphedema in patientsundergoing ALND. The mechanism of action may be multifactorial and not limited to weight reduction and insulin resistance. Future prospective analysis is warranted to clarify the role of GLP-1RAs in reducing lymphedema risk.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1457363","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:23:11Z","timestamp":1725427391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)"],"prefix":"10.3389","volume":"15","author":[{"given":"Stav","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audree B.","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajah","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jso.24969","article-title":"Staged surgical treatment of extremity lymphedema with dual gastroepiploic vascularized lymph node transfers followed by suction-assisted lipectomy-A prospective study","volume":"117","author":"Agko","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/sap.0000000000000513","article-title":"Comparison of vascularized supraclavicular lymph node transfer and lymphaticovenular anastomosis for advanced stage lower extremity lymphedema","volume":"74","author":"Akita","year":"2015","journal-title":"Ann. Plast. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"101923","DOI":"10.1016\/j.jsps.2023.101923","article-title":"Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K\/Akt\/mTOR signaling pathway","volume":"32","author":"Alanteet","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1559325821995651","DOI":"10.1177\/1559325821995651","article-title":"Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines' expression in adipocytes and cancer cells","volume":"19","author":"Alanteet","year":"2021","journal-title":"Dose Response"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20420188231222367","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"B6","unstructured":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"C589","DOI":"10.1152\/ajpcell.00535.2009","article-title":"Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis","volume":"299","author":"Avraham","year":"2010","journal-title":"Am. J. physiology Cell physiology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1096\/fj.12-222695","article-title":"Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema","volume":"27","author":"Avraham","year":"2013","journal-title":"Faseb J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1002\/ctm2.758","article-title":"TGF-\u03b21 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation","volume":"12","author":"Baik","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1097\/sla.0000000000004457","article-title":"Outcomes for physiologic microsurgical treatment of secondary lymphedema involving the extremity","volume":"276","author":"Beederman","year":"2020","journal-title":"Ann. Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists","volume":"182","author":"Bendotti","year":"","journal-title":"Pharmacol. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1245\/s10434-008-0270-y","article-title":"Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy","volume":"16","author":"Boccardo","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/micr.30855","article-title":"Combined lymph node transfer and suction-assisted lipectomy in lymphedema treatment: a prospective study","volume":"42","author":"Bolletta","year":"2022","journal-title":"Microsurgery"},{"key":"B14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.amjsurg.2009.06.008","article-title":"Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy","volume":"198","author":"Boneti","year":"2009","journal-title":"Am. J. Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","article-title":"Financial cost of lymphedema borne by women with breast cancer","volume":"26","author":"Boyages","year":"2017","journal-title":"Psychooncology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1028926","DOI":"10.3389\/fphar.2022.1028926","article-title":"Doxycycline for the treatment of breast cancer-related lymphedema","volume":"13","author":"Brown","year":"","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"330e","DOI":"10.1097\/prs.0000000000009866","article-title":"The vicious circle of stasis, inflammation, and fibrosis in lymphedema","volume":"151","author":"Brown","year":"","journal-title":"Plast. Reconstr. Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e5747","DOI":"10.1097\/gox.0000000000005747","article-title":"Immediate lymphatic reconstruction with vascularized omentum lymph node transplant: reducing the risk of both painful contracture and lymphedema","volume":"12","author":"Brown","year":"2024","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/sla.0000000000005591","article-title":"A prospective study on the safety and efficacy of vascularized lymph node transplant","volume":"276","author":"Brown","year":"","journal-title":"Ann. Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2023.01.005","article-title":"Topical captopril: a promising treatment for secondary lymphedema","volume":"257","author":"Brown","year":"","journal-title":"Transl. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.GOX.0000992220.91793.a6","article-title":"The association between lymphedema and autoimmunity: a large case control study","volume":"11","author":"Brown","year":"","journal-title":"Plast. Reconstr. Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1200\/JCO.1990.8.8.1327","article-title":"Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer","volume":"8","author":"Camoriano","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.1111\/j.1749-6632.2010.05752.x","article-title":"Lymphatic system: a vital link between metabolic syndrome and inflammation","volume":"1207","author":"Chakraborty","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"676e","DOI":"10.1097\/prs.0000000000006634","article-title":"Optimizing quality of life for patients with breast cancer-related lymphedema: a prospective study combining diep flap breast reconstruction and lymphedema surgery","volume":"145","author":"Chang","year":"2020","journal-title":"Plast. Reconstr. Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"997578","DOI":"10.3389\/fimmu.2022.997578","article-title":"GLP-1 receptor agonist as a modulator of innate immunity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/PRS.0b013e31828bd3b3","article-title":"Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes","volume":"131","author":"Cheng","year":"2013","journal-title":"Plast. Reconstr. Surg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00063030-200620060-00007","article-title":"An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis","volume":"20","author":"Cheung","year":"2006","journal-title":"BioDrugs Clin. Immunother. Biopharm. gene Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"H2113","DOI":"10.1152\/ajpheart.00879.2008","article-title":"TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair","volume":"295","author":"Clavin","year":"2008","journal-title":"Am. J. physiology Heart circulatory physiology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/sla.0000000000005952","article-title":"Efficacy of immediate lymphatic reconstruction to decrease incidence of breast cancer-related lymphedema: preliminary results of randomized controlled trial","volume":"278","author":"Coriddi","year":"2023","journal-title":"Ann. Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/jso.26783","article-title":"Outcomes and technical modifications of vascularized lymph node transplantation from the lateral thoracic region for treatment of lymphedema","volume":"125","author":"Coroneos","year":"2022","journal-title":"J. Surg. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jamcollsurg.2013.12.041","article-title":"Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results","volume":"218","author":"Cowher","year":"2014","journal-title":"J. Am. Coll. Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/ijms22094455","article-title":"The kinetics of lymphatic dysfunction and leukocyte expansion in the draining lymph node during LTB(4) antagonism in a mouse model of lymphedema","volume":"22","author":"Cribb","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1392375","DOI":"10.3389\/fonc.2024.1392375","article-title":"GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report","volume":"14","author":"Crowley","year":"2024","journal-title":"Front. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2350408","DOI":"10.1001\/jamanetworkopen.2023.50408","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes","volume":"7","author":"Dankner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/prs.0000000000000822","article-title":"Reverse lymphatic mapping: a new technique for maximizing safety in vascularized lymph node transfer","volume":"135","author":"Dayan","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1371\/journal.ppat.0020092","article-title":"Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis","volume":"2","author":"Debrah","year":"2006","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10549-016-3716-0","article-title":"A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer","volume":"156","author":"Dionyssiou","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"B38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/micr.30641","article-title":"A prospective study on combined lymphedema surgery: gastroepiploic vascularized lymph nodes transfer and lymphaticovenous anastomosis followed by suction lipectomy","volume":"41","author":"Di Taranto","year":"2021","journal-title":"Microsurgery"},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/lrb.2019.0072","article-title":"Is there a relationship between insulin resistance and breast cancer-related lymphedema? A preliminary study","volume":"20","author":"Doruk Analan","year":"2022","journal-title":"Lymphat. Res. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.metabol.2016.03.009","article-title":"Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study","volume":"65","author":"Farr","year":"2016","journal-title":"Metabolism"},{"key":"B41","unstructured":"Highlights of prescribing information - OZEMPIC2020"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.1245\/s10434-022-12035-9","article-title":"Vascularized lymph node transfer improved outcomes of elderly patients with secondary upper extremity lymphedema","volume":"29","author":"Francis","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e140853","DOI":"10.1172\/jci140853","article-title":"Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis","volume":"131","author":"Furlong-Silva","year":"2021","journal-title":"J. Clin. investigation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1467-789X.2011.00957.x","article-title":"Importance of metabolic changes induced by chemotherapy on prognosis of early\u2010stage breast cancer patients: a review of potential mechanisms","volume":"13","author":"Gadea","year":"2012","journal-title":"Obes. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41467-018-04418-y","article-title":"CD4(+) T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema","volume":"9","author":"Garc\u00eda Nores","year":"2018","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"14345","DOI":"10.1038\/ncomms14345","article-title":"Topical tacrolimus for the treatment of secondary lymphedema","volume":"8","author":"Gardenier","year":"2017","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/prs.0000000000009247","article-title":"Physical and functional outcomes of simultaneous vascularized lymph node transplant and lymphovenous bypass in the treatment of lymphedema","volume":"150","author":"Garza","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.intimp.2014.07.010","article-title":"Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-\u03baB in mice","volume":"22","author":"Gou","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1245\/s10434-016-5614-4","article-title":"Clinical and psychosocial outcomes of vascularized lymph node transfer for the treatment of upper extremity lymphedema after breast cancer therapy","volume":"24","author":"Gratzon","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biomaterials.2016.05.040","article-title":"Aligned nanofibrillar collagen scaffolds - guiding lymphangiogenesis for treatment of acquired lymphedema","volume":"102","author":"Hadamitzky","year":"2016","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamainternmed.2022.0335","article-title":"Glucagon-like peptide-1 receptor agonists-how safe are they?","volume":"182","author":"Haider","year":"2022","journal-title":"JAMA Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1524-4741.2009.00855.x","article-title":"Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients","volume":"16","author":"Helyer","year":"","journal-title":"breast J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1524-4741.2009.00855.x","article-title":"Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients","volume":"16","author":"Helyer","year":"","journal-title":"Breast J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/circulationaha.107.735795","article-title":"New drugs for the treatment of diabetes: part II: incretin-based therapy and beyond","volume":"117","author":"Inzucchi","year":"2008","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s11695-023-06484-8","article-title":"Efficacy of the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide for the treatment of weight regain after bariatric surgery: a retrospective observational study","volume":"33","author":"Jensen","year":"2023","journal-title":"Obes. Surg."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1007\/s12325-022-02153-x","article-title":"Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review","volume":"39","author":"Jensterle","year":"2022","journal-title":"Adv. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2009.0002","article-title":"Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization","volume":"7","author":"Jin","year":"2009","journal-title":"Lymphatic Res. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"373e","DOI":"10.1097\/prs.0000000000007636","article-title":"Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema","volume":"147","author":"Johnson","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/jso.25177","article-title":"Immediate lymphatic reconstruction","volume":"118","author":"Johnson","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2019.04.001","article-title":"Fibrosis and secondary lymphedema: chicken or egg?","volume":"209","author":"Kataru","year":"2019","journal-title":"Transl. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e12492","DOI":"10.1111\/micc.12492","article-title":"Insulin resistance disrupts cell integrity, mitochondrial function, and inflammatory signaling in lymphatic endothelium","volume":"25","author":"Lee","year":"2018","journal-title":"Microcirculation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3390\/ijms21072546","article-title":"Histopathologic features of lymphedema: a molecular review","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e58445","DOI":"10.1371\/journal.pone.0058445","article-title":"Glucagon-like peptide-1 (9-36) inhibits chemokine-induced migration of human CD4-positive lymphocytes","volume":"8","author":"Liberman","year":"2013","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10549-011-1585-0","article-title":"The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells","volume":"132","author":"Ligumsky","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"B67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jso.25523","article-title":"Factors associated with professional healthcare advice seeking in breast cancer-related lymphedema","volume":"121","author":"Lin","year":"2020","journal-title":"J. Surg. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"120370","DOI":"10.1016\/j.lfs.2022.120370","article-title":"Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4\/ROS\/VEGF pathway","volume":"294","author":"Liu","year":"2022","journal-title":"Life Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/jcm11030570","article-title":"The combination of lymph node transfer and excisional procedures in bilateral lower extremity lymphedema: clinical outcomes and quality of life assessment with long-term follow-up","volume":"11","author":"Losco","year":"2022","journal-title":"J. Clin. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"518e","DOI":"10.1097\/prs.0000000000005322","article-title":"Small numbers of CD4+ T cells can induce development of lymphedema","volume":"143","author":"Ly","year":"2019","journal-title":"Plast. Reconstr. Surg."},{"key":"B71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jso.24351","article-title":"The use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases","volume":"115","author":"Maldonado","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/cid\/cis486","article-title":"Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial","volume":"55","author":"Mand","year":"2012","journal-title":"Clin. Infect. Dis. official Publ. Infect. Dis. Soc. Am."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: part 1: definitions, assessments, education, and future directions","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/jco.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"154e","DOI":"10.1097\/prs.0000000000000268","article-title":"Lymphedema and obesity: is there a link?","volume":"134","author":"Mehrara","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"B77","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/biology10090934","article-title":"Pilot study of anti-Th2 immunotherapy for the treatment of breast cancer-related upper extremity lymphedema","volume":"10","author":"Mehrara","year":"2021","journal-title":"Biology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","article-title":"Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema","volume":"8","author":"Montagna","year":"2022","journal-title":"JAMA Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"102834","DOI":"10.1016\/j.dsx.2023.102834","article-title":"Semaglutide and cancer: a systematic review and meta-analysis","volume":"17","author":"Nagendra","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e8380","DOI":"10.1371\/journal.pone.0008380","article-title":"Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice","volume":"4","author":"Nakamura","year":"2009","journal-title":"PloS one"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1158\/1055-9965.EPI-08-1094","article-title":"Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality","volume":"18","author":"Nichols","year":"2009","journal-title":"Cancer Epidemiol. biomarkers and Prev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/jco.2008.17.9291","article-title":"Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms","volume":"27","author":"Norman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"H1159","DOI":"10.1152\/ajpheart.00574.2023","article-title":"GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage","volume":"326","author":"Park","year":"2024","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1245\/s10434-014-4276-3","article-title":"A prospective evaluation of lymphedema-specific quality-of-life outcomes following vascularized lymph node transfer","volume":"22","author":"Patel","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::aid-cncr1459>3.0.co;2-9","article-title":"Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis","volume":"92","author":"Petrek","year":"2001","journal-title":"Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.clbc.2017.11.006","article-title":"Determinants of weight gain during adjuvant endocrine therapy and association of such weight gain with recurrence in long-term breast cancer survivors","volume":"18","author":"Raghavendra","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1002\/cncr.34489","article-title":"Burden of lymphedema in long-term breast cancer survivors by race and age","volume":"128","author":"Ren","year":"2022","journal-title":"Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamaoncol.2020.7891","article-title":"Financial burden of lymphedema hospitalizations in the United States","volume":"7","author":"Roberson","year":"2021","journal-title":"JAMA Oncol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1002\/cncr.33819","article-title":"Weight loss does not decrease risk of breast cancer-related arm lymphedema","volume":"127","author":"Roberts","year":"2021","journal-title":"Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jamasurg.2023.2414","article-title":"Feasibility and clinical utility of prediction models for breast cancer-related lymphedema incorporating racial differences in disease incidence","volume":"158","author":"Rochlin","year":"2023","journal-title":"JAMA Surg."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment","volume":"379","author":"Rockson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e123775","DOI":"10.1172\/jci.insight.123775","article-title":"Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema","volume":"3","author":"Rockson","year":"2018","journal-title":"JCI insight"},{"key":"B93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/bd-210043","article-title":"Risk factors for lymphedema after breast surgery: a prospective cohort study in the era of sentinel lymph node biopsy","volume":"41","author":"Salinas-Huertas","year":"2021","journal-title":"Breast Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/cas.14457","article-title":"Potential role of transforming growth factor-beta 1\/Smad signaling in secondary lymphedema after cancer surgery","volume":"111","author":"Sano","year":"2020","journal-title":"Cancer Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jamcollsurg.2021.03.002","article-title":"Outcomes of vascularized lymph node transplantation for treatment of lymphedema","volume":"232","author":"Schaverien","year":"2021","journal-title":"J. Am. Coll. Surg."},{"key":"B96","doi-asserted-by":"publisher","first-page":"700e","DOI":"10.1097\/prs.0000000000008960","article-title":"Jejunal mesenteric vascularized lymph node transplantation for lymphedema: outcomes and technical modifications","volume":"149","author":"Schaverien","year":"2022","journal-title":"Plast. Reconstr. Surg."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/jnci\/djt223","article-title":"Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity","volume":"105","author":"Schmitz","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jamaoncol.2019.2109","article-title":"Effect of home-based exercise and weight loss programs on breast cancer\u2013related lymphedema outcomes among overweight breast cancer survivors: the WISER survivor randomized clinical trial","volume":"5","author":"Schmitz","year":"2019","journal-title":"JAMA Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/a-1345-7890","article-title":"Growth promotion and increased ATP-binding cassette transporters expression by liraglutide in triple negative breast cancer cell line MDA-MB-231","volume":"71","author":"Shadboorestan","year":"2021","journal-title":"Drug Res. (Stuttg)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11154-014-9289-5","article-title":"Effects of GLP-1 on appetite and weight","volume":"15","author":"Shah","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/cncr.22994","article-title":"A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema","volume":"110","author":"Shaw","year":"","journal-title":"Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1002\/cncr.22638","article-title":"Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema","volume":"109","author":"Shaw","year":"","journal-title":"Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","article-title":"Therapeutic lymphangiogenesis with human recombinant VEGF-C","volume":"16","author":"Szuba","year":"2002","journal-title":"FASEB J. official Publ. Fed. Am. Soc. Exp. Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"eaal3920","DOI":"10.1126\/scitranslmed.aal3920","article-title":"Leukotriene B(4) antagonism ameliorates experimental lymphedema","volume":"9","author":"Tian","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1111\/all.14879","article-title":"Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice","volume":"76","author":"Toki","year":"2021","journal-title":"Allergy"},{"key":"B106","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/1097-0142(195705\/06)10:3<444::aid-cncr2820100306>3.0.co;2-7","article-title":"An evaluation of the etiological factors of lymphedema following radical mastectomy. An analysis of 1,007 cases","volume":"10","author":"Treves","year":"1957","journal-title":"Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/sla.0000000000001778","article-title":"Does axillary reverse mapping prevent lymphedema after lymphadenectomy?","volume":"265","author":"Tummel","year":"2017","journal-title":"Ann. Surg."},{"key":"B108","volume-title":"Ubenimex in Adult patients with lymphedema of the lower limb (ULTRA)","year":"2021"},{"key":"B109","volume-title":"GILENYA (fingolimod)","year":""},{"key":"B110","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2024.04.029","article-title":"Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes","volume":"167","author":"Wang","year":"","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamaoncol.2023.5573","article-title":"GLP-1 receptor agonists and colorectal cancer risk in drug-naive patients with type 2 diabetes, with and without overweight\/obesity","volume":"10","author":"Wang","year":"","journal-title":"JAMA Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiology.180.1.2052688","article-title":"Arm edema in conservatively managed breast cancer: obesity is a major predictive factor","volume":"180","author":"Werner","year":"1991","journal-title":"Radiology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1245\/ASO.2006.05.013","article-title":"Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial","volume":"13","author":"Wilke","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/1744666x.2021.1971973","article-title":"The GLP-1 receptor in airway inflammation in asthma: a promising novel target?","volume":"17","author":"Wu","year":"2021","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/lrb.2018.0070","article-title":"EW-7197, a transforming growth factor-beta type I receptor kinase inhibitor, ameliorates acquired lymphedema in a mouse tail model","volume":"18","author":"Yoon","year":"2020","journal-title":"Lymphat. Res. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e49940","DOI":"10.1371\/journal.pone.0049940","article-title":"CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis","volume":"7","author":"Zampell","year":"2012","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3892\/mmr.2018.8475","article-title":"Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression","volume":"17","author":"Zhao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B118","doi-asserted-by":"publisher","first-page":"721135","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1457363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T07:42:10Z","timestamp":1725954130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1457363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":118,"alternative-id":["10.3389\/fphar.2024.1457363"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1457363","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"article-number":"1457363"}}